ArticlePLoS computational biology2023

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.

Maria Kalweit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.